182 related articles for article (PubMed ID: 37020354)
1. Progress in vaccine development for infectious diseases-a Keystone Symposia report.
Cable J; Graham BS; Koup RA; Seder RA; Karikó K; Pardi N; Barouch DH; Sharma B; Rauch S; Nachbagauer R; Forsell MNE; Schotsaert M; Ellebedy AH; Loré K; Irvine DJ; Pilkington E; Tahtinen S; Thompson EA; Feraoun Y; King NP; Saunders K; Alter G; Moin SM; Sliepen K; Karlsson Hedestam GB; Wardemann H; Pulendran B; Doria-Rose NA; He WT; Juno JA; Ataca S; Wheatley AK; McLellan JS; Walker LM; Lederhofer J; Lindesmith LC; Wille H; Hotez PJ; Bekker LG
Ann N Y Acad Sci; 2023 Jun; 1524(1):65-86. PubMed ID: 37020354
[TBL] [Abstract][Full Text] [Related]
2. Innovative vaccine approaches-a Keystone Symposia report.
Cable J; Rappuoli R; Klemm EJ; Kang G; Mutreja A; Wright GJ; Pizza M; Castro SA; Hoffmann JP; Alter G; Carfi A; Pollard AJ; Krammer F; Gupta RK; Wagner CE; Machado V; Modjarrad K; Corey L; B Gilbert P; Dougan G; Lurie N; Bjorkman PJ; Chiu C; Nemes E; Gordon SB; Steer AC; Rudel T; Blish CA; Sandberg JT; Brennan K; Klugman KP; Stuart LM; Madhi SA; Karp CL
Ann N Y Acad Sci; 2022 May; 1511(1):59-86. PubMed ID: 35029310
[TBL] [Abstract][Full Text] [Related]
3. The mRNA vaccine, a swift warhead against a moving infectious disease target.
Mir S; Mir M
Expert Rev Vaccines; 2024; 23(1):336-348. PubMed ID: 38369742
[TBL] [Abstract][Full Text] [Related]
4. Exploring future perspectives and pipeline progression in vaccine research and development.
Vecchio R; Gentile L; Tafuri S; Costantino C; Odone A
Ann Ig; 2024; 36(4):446-461. PubMed ID: 38436081
[TBL] [Abstract][Full Text] [Related]
5. Vaccinomics: a future avenue for vaccine development against emerging pathogens.
de la Fuente J; Contreras M
Expert Rev Vaccines; 2021 Dec; 20(12):1561-1569. PubMed ID: 34582295
[TBL] [Abstract][Full Text] [Related]
6. Two centuries of vaccination: historical and conceptual approach and future perspectives.
Montero DA; Vidal RM; Velasco J; Carreño LJ; Torres JP; Benachi O MA; Tovar-Rosero YY; Oñate AA; O'Ryan M
Front Public Health; 2023; 11():1326154. PubMed ID: 38264254
[TBL] [Abstract][Full Text] [Related]
7. Endemic, epidemic and pandemic infections: the roles of natural and acquired herd immunity.
Stevens DL; Bryant AE
Curr Opin Infect Dis; 2023 Jun; 36(3):171-176. PubMed ID: 36939580
[TBL] [Abstract][Full Text] [Related]
8. Vaccine innovations for emerging infectious diseases-a symposium report.
Cable J; Srikantiah P; Crowe JE; Pulendran B; Hill A; Ginsberg A; Koff W; Mathew A; Ng T; Jansen K; Glenn G; Permar S; Wilson I; Weiner DB; Weissman D; Rappuoli R
Ann N Y Acad Sci; 2020 Feb; 1462(1):14-26. PubMed ID: 31659752
[TBL] [Abstract][Full Text] [Related]
9. Historical Advances in Structural and Molecular Biology and How They Impacted Vaccine Development.
Koff WC; Rappuoli R; Plotkin SA
J Mol Biol; 2023 Jul; 435(13):168113. PubMed ID: 37080423
[TBL] [Abstract][Full Text] [Related]
10. From influenza to COVID-19: Lipid nanoparticle mRNA vaccines at the frontiers of infectious diseases.
Pilkington EH; Suys EJA; Trevaskis NL; Wheatley AK; Zukancic D; Algarni A; Al-Wassiti H; Davis TP; Pouton CW; Kent SJ; Truong NP
Acta Biomater; 2021 Sep; 131():16-40. PubMed ID: 34153512
[TBL] [Abstract][Full Text] [Related]
11. Impact of pandemics and disruptions to vaccination on infectious diseases epidemiology past and present.
Hamson E; Forbes C; Wittkopf P; Pandey A; Mendes D; Kowalik J; Czudek C; Mugwagwa T
Hum Vaccin Immunother; 2023 Aug; 19(2):2219577. PubMed ID: 37291691
[TBL] [Abstract][Full Text] [Related]
12. Malaria & mRNA Vaccines: A Possible Salvation from One of the Most Relevant Infectious Diseases of the Global South.
Borkens Y
Acta Parasitol; 2023 Dec; 68(4):916-928. PubMed ID: 37828249
[TBL] [Abstract][Full Text] [Related]
13. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
Amanpour S
Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 vaccine hesitancy - reasons and solutions to achieve a successful global vaccination campaign to tackle the ongoing pandemic.
Dhama K; Sharun K; Tiwari R; Dhawan M; Emran TB; Rabaan AA; Alhumaid S
Hum Vaccin Immunother; 2021 Oct; 17(10):3495-3499. PubMed ID: 34191680
[TBL] [Abstract][Full Text] [Related]
15. Vaccinology in the post-COVID-19 era.
Rappuoli R; De Gregorio E; Del Giudice G; Phogat S; Pecetta S; Pizza M; Hanon E
Proc Natl Acad Sci U S A; 2021 Jan; 118(3):. PubMed ID: 33431690
[TBL] [Abstract][Full Text] [Related]
16. Recent Advances in the Molecular Design and Delivery Technology of mRNA for Vaccination Against Infectious Diseases.
Yang L; Tang L; Zhang M; Liu C
Front Immunol; 2022; 13():896958. PubMed ID: 35928814
[TBL] [Abstract][Full Text] [Related]
17. Prototype Pathogen Approach for Vaccine and Monoclonal Antibody Development: A Critical Component of the NIAID Plan for Pandemic Preparedness.
Cassetti MC; Pierson TC; Patterson LJ; Bok K; DeRocco AJ; Deschamps AM; Graham BS; Erbelding EJ; Fauci AS
J Infect Dis; 2023 Jun; 227(12):1433-1441. PubMed ID: 35876700
[TBL] [Abstract][Full Text] [Related]
18. Vaccine development: Current trends and technologies.
Poria R; Kala D; Nagraik R; Dhir Y; Dhir S; Singh B; Kaushik NK; Noorani MS; Kaushal A; Gupta S
Life Sci; 2024 Jan; 336():122331. PubMed ID: 38070863
[TBL] [Abstract][Full Text] [Related]
19. Vaccine hesitancy in the era of COVID-19: could lessons from the past help in divining the future?
Wiysonge CS; Ndwandwe D; Ryan J; Jaca A; Batouré O; Anya BM; Cooper S
Hum Vaccin Immunother; 2022 Dec; 18(1):1-3. PubMed ID: 33684019
[TBL] [Abstract][Full Text] [Related]
20. Mitigating Covid-19 in the face of emerging virus variants, breakthrough infections and vaccine hesitancy.
Haque A; Pant AB
J Autoimmun; 2022 Feb; 127():102792. PubMed ID: 34995958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
